Akcea Therapeutics Quote - AKCA | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Akcea Therapeutics Inc (AKCA) Share Price

Akcea Therapeutics Inc (AKCA)

18.17

0.00

(0.00%)

Closed March 03 3:00PM

Delayed by 15 minutes

0.00

0.00

(0.00%)

After Hours: -

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Current Price

18.17

Bid

18.08

Ask

19.00

Volume

-

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

18.17

Open

-

Last Trade

Last Trade Time

Average Volume (3m)

-

Financial Volume

-

VWAP

-

Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product

Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product PR...

Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics

Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics Transaction creates a stronger, more...

WAYLIVRA▼® (volanesorsen), the First & Only Therapy for FCS, an Ultra-Rare & Life-Threatening Condition, to Be Available o...

National Institute for Health and Care Excellence (NICE) issues a positive recommendation for volanesorsen to treat adults with Familial...

Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics

Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics - Ionis to acquire remaining 24% of...

Positive Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L(Rx)) Presented at ESC Congress 2020

Positive Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L(Rx)) Presented at ESC Congress 2020 Results from Phase 2 study demonstrate patients...

Positive Phase 2 Clinical Data of AKCEA-APOCIII-L(Rx) Presented at ESC Congress 2020

Positive Phase 2 Clinical Data of AKCEA-APOCIII-L(Rx) Presented at ESC Congress 2020 Results in late-breaking...

Akcea and Ionis to Present Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L (Rx) ) at ESC Congress 2020

Akcea and Ionis to Present Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L (Rx) ) at ESC Congress...

Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC Congress 2020

Akcea and Ionis to Present Phase 2 Results of AKCEA-APOCIII-L(Rx) in Late-Breaking Presentation at ESC...

Akcea Announces New Pricing and Reimbursement of WAYLIVRA® (volanesorsen) in Germany

Akcea Announces New Pricing and Reimbursement of WAYLIVRA® (volanesorsen) in Germany WAYLIVRA is the only...

Akcea Reports Financial Results and Highlights for Second Quarter 2020

Akcea Reports Financial Results and Highlights for Second Quarter 2020 Global Net Product Revenues of $16...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

AKCA - Frequently Asked Questions (FAQ)

What is the current Akcea Therapeutics share price?

The current share price of Akcea Therapeutics is US$ 18.17

What is the 1 year trading range for Akcea Therapeutics share price?

Akcea Therapeutics has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ACONAclarion Inc	US$ 7.511 (124.21%)	90.42M
BTOGBit Origin Ltd	US$ 0.3209 (76.32%)	292.41M
BTAIBioXcel Therapeutics Inc	US$ 3.73 (72.69%)	146.89M
CLROClearOne Inc	US$ 0.78 (50.87%)	33.41M
ATLNAtlantic International Corporation	US$ 3.1674 (50.11%)	615.27k
BLNEEastside Distilling Inc	US$ 0.7237 (-90.57%)	51.81k
NVNINVNI Group Ltd	US$ 0.3798 (-62.40%)	37.8M
AGMHAGM Group Holdings Inc	US$ 0.1304 (-60.32%)	9.41M
PLRXPliant Therapeutics Inc	US$ 1.38 (-59.88%)	19.44M
AGHAureus Greenway Holdings Inc	US$ 2.23 (-59.01%)	3.79M
NVDANVIDIA Corporation	US$ 114.06 (-8.69%)	409.27M
BTOGBit Origin Ltd	US$ 0.3209 (76.32%)	290.83M
FTFTFuture FinTech Group Inc	US$ 0.249 (23.27%)	218.53M
SPGCSacks Parente Golf Inc	US$ 0.187 (-10.35%)	160.2M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 12.6667 (-5.82%)	153.46M

Sidney

Sidney 7 years ago

Any thoughts on why so low today?

Thoro

Thoro 8 years ago

So Volatile. Any thoughts on why the big plunge today?

Rodney213

Rodney213 8 years ago

Like how clean the board is .Some heavy price target coverage today

dinosaurbob

dinosaurbob 8 years ago

Dropped heavy yesterday but bounced back some today. I am still up 17%, so I am not complaining.

Thoro

Thoro 8 years ago

This is a volatile stock. Its finding its legs.

dinosaurbob

dinosaurbob 8 years ago

Closed at $15.43 today up 47 cents.

dinosaurbob

dinosaurbob 8 years ago

Back up $1.02 today. This stock is like riding a roller coaster. Up one day and down the next. And big drops and rises too.

dinosaurbob

dinosaurbob 8 years ago

WTH happened today? Down $1.52!

dinosaurbob

dinosaurbob 8 years ago

Closed up 40 cents at $14.88

dinosaurbob

dinosaurbob 8 years ago

It was up big earlier but steadily dropping now. Still up 14 cents at 2:45 EST

Thoro

Thoro 8 years ago

AKCA, Akcea and Ionis Announce Submission of Marketing Authorization Application for Volanesorsen to the European Medicines Agency

https://ih.advfn.com/p.php?pid=nmona&article=75321782

dinosaurbob

dinosaurbob 8 years ago

Closed up at $14.48 (5.16%). Nice!

Thoro

Thoro 8 years ago

I know it dropped, but I like when it tests higher.

dinosaurbob

dinosaurbob 8 years ago

Yes, but it dropped to $13.77. I still believe in it though.

Thoro

Thoro 8 years ago

AKCA $16.30 looked great today!

dinosaurbob

dinosaurbob 8 years ago

I bought in at 9.88 and then doubled my portfolio Friday at $13.00. I see this over $20.00 by October!

Thoro

Thoro 8 years ago

AKCA

IPO doing great first 5 days of trading.

Thoro

Thoro 8 years ago

AKCA

#MARKET NEWS
JULY 14, 2017 / 12:12 PM / 3 DAYS AGO
BRIEF-Akcea Therapeutics Inc shares open at $8.13 in debut vs IPO price of $8/share

http://www.reuters.com/article/brief-akcea-therapeutics-inc-shares-open-idUSFWN1K50CZ

Thoro

Thoro 8 years ago

AKCA

#MARKET NEWS
JULY 13, 2017 / 8:30 PM / 4 DAYS AGO

BRIEF-Akcea Therapeutics says public offering of 15.6 mln common shares priced at $8 per share

http://www.reuters.com/article/brief-akcea-therapeutics-says-public-off-idUSASA09X2O

Akcea Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions